DRK-BLUTSPENDEDIENST BADEN-WURTTEMBERG-HESSEN GGMBH

Their core work

DRK-BSD is the German Red Cross Blood Donation Service for Baden-Württemberg and Hesse — one of Germany's largest regional blood banks, collecting, testing, processing and distributing blood components and plasma products to hospitals. Beyond routine transfusion services, their Mannheim operation runs GMP-grade cell processing facilities that support advanced therapy research, including cellular immunotherapy manufacturing. In EU research they act as a clinical and operational partner: they supply patient-donor material, run quality-controlled plasma programs, and handle the regulated manufacturing steps that academic labs cannot easily do themselves. Think of them as the industrial-scale bridge between laboratory cell therapy and real patient treatment.

What they specialise in

How they've shifted over time

Between 2018 and 2020 their H2020 focus shifted sharply from advanced oncology cellular therapy (CAR T-cell manufacturing for multiple myeloma in CARAMBA) to pandemic-response transfusion medicine (COVID-19 convalescent plasma in SUPPORT-E). The pivot tracks Europe's broader health emergency priorities and plays directly to their core infrastructure — large-scale donor recruitment and plasma processing. Underneath both projects sits a consistent thread: they are the partner who can actually collect, process, and release patient-grade blood products at regulated quality.

Positioned to contribute to any future European program that needs regulated plasma supply, antibody-therapy clinical logistics, or GMP cell processing — especially in pandemic preparedness and advanced therapy medicinal products (ATMPs).

How they like to work

DRK-BSD consistently joins as a participant rather than leading, contributing operational and GMP capabilities inside academic-led consortia. Across their two projects they have worked with 22 distinct partners across 9 countries, which suggests they are an open collaborator rather than a closed club. Partner them when you need real-world blood/plasma logistics and regulatory execution attached to a scientific idea — not when you need a project coordinator.

Connected to 22 unique H2020 partners spanning 9 European countries, with activity rooted in Mannheim but reaching across EU health research networks. Geographic footprint is European, not local, though their donor base remains regional.

What sets them apart

Unlike most health research participants (universities, hospitals, biotechs), DRK-BSD is a working blood service — they collect from donors, release products to clinics, and operate under strict transfusion regulation every day. That operational reality is rare in a research consortium and hard to replicate: few partners can both run a phase-relevant clinical logistic and contribute to scientific work. If your project needs plasma, cellular starting material, or GMP release of a cell-based product delivered to patients at scale, they are one of the few organizations in Germany who can actually do it.

Highlights from their portfolio

• SUPPORT-E
  Their largest H2020 participation (EUR 2.1M), aligning directly with core plasma-service capability and Europe's COVID-19 emergency response.
• CARAMBA
  Demonstrates capacity well beyond routine blood banking — GMP manufacturing of gene-modified CAR T cells using the non-viral Sleeping Beauty system.